Barclays raised the firm’s price target on Dynatrace (DT) to $62 from $55 and keeps an Overweight rating on the shares. The company’s fiscal Q4 Q4 “was healthy across the board,” with Dynatrace executing well in closing large deals despite the uncertain macro environment, the analyst tells investors in a research note. The firm says the company’s guidance incorporates an “incremental level of prudence in response to uncertainty,” which sets Dynatrace up well for “consistent healthy beats” in fiscal 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DT:
- Dynatrace’s Strong Q4 Performance and Strategic Positioning Justify Buy Rating
- Dynatrace Reports Strong Fiscal 2025 Results
- Dynatrace price target raised to $55 from $50 at Morgan Stanley
- Dynatrace Hold Rating: Balancing Stable Growth with Cautious Outlook
- Dynatrace price target raised to $65 from $60 at Jefferies
